20幎12æã11æã«ç¶ããŠã飲é£æ¥ã®ç¶æ³ã¯æªåãããšãã調æ»çºè¡šããã£ãã
20幎9æã«ããŒã¯ãè¿ããåŸã10æ以éã¯3ãæé£ç¶ã§å£²ãäžããæžå°ãããããšãšãªãããŸã売äžé«ã®æžå°ã«äŒŽãçŽ40äžäººã®éçšãåæžããã
å·åäœã§èŠããšå šç±³42å·ã§éçšãæžå°ããŠãããéçšãå¢å ããã®ã¯8å·ã®ã¿ãšãªã£ãã
以äžãéçšãæžå°ãããå·ãæžå°æ°ã®å€ãé ã«ãªã¹ãã¢ããããïŒ
ãã«ãªãã©ã«ãã¢å·ïŒ 8.58äžäºº
ããã·ã¬ã³å·ïŒ4.66äžäºº
ããã¥ãŒãšãŒã¯å·ïŒ3.3äžäºº
ããããœã¿å·ïŒ3.28äžäºº
ãã€ãªãã€å·ïŒ2.43äžäºº
20幎12ææç¹ã§ã¯ã46å·ãšã¯ã·ã³ãã³DCã®ã¬ã¹ãã©ã³ã®éçšäººæ°ã¯COVID-19åã®2æã®æ°Žæºãäžåã£ããŸãŸã§ãããäžã§ã15å·ãšã¯ã·ã³ãã³DCã§ã¯25%以äžæžå°ããŠããã
ãããŒã¢ã³ãå·ïŒ45%æž
ããã·ã¬ã³å·ïŒ44%æž
ããããœã¿å·ïŒ38%æž
ãDCïŒ35%æž
ããªã¬ãŽã³å·ïŒ34%æž
ããã¥ãŒãšãŒã¯å·ïŒ34%æž
ãã·ã·ããå·ãã€ã³ãã£ã¢ãå·ããªã¯ã©ããå·ã®3å·ã¯ãCOVID-19åã®2æã®æ°Žæºä»¥äžã®æ±äººããã£ãã